Literature DB >> 7606914

Growth and virulence of a complement-activation-negative mutant of Streptococcus pneumoniae in the rabbit cornea.

M K Johnson1, M C Callegan, L S Engel, R J O'Callaghan, J M Hill, J A Hobden, G J Boulnois, P W Andrew, T J Mitchell.   

Abstract

Our previous work has demonstrated the importance of pneumolysin in the virulence of S. pneumoniae in a rabbit intracorneal model. This was accomplished by showing that deletion of the gene encoding pneumolysin resulted in reduced virulence, whereas restoration of the wild-type gene resulted in restoration of the virulent phenotype. To assess the importance of a particular domain in the pneumolysin molecule, we have now constructed a strain which produces a pneumolysin molecule which is hemolytic but which bears a site-specific mutation in the domain known to be associated with the complement-activating properties of this molecule. Comparison of the virulence of this strain with that of a strain bearing the wild-type gene showed statistically significantly lower total slit lamp examination (SLE) scores at 12, 18, 24, and 36 h (particularly with respect to fibrin formation), but no difference at 48 h. Determination of colony forming units (CFU) in eyes infected with the two strains showed approximately 10(6) bacteria per cornea until 36 h. Between 36 and 48 h, the bacteria were almost completely cleared with very few bacteria recoverable at the later time point. The loss of virulence observed with this mutation in the complement-activation domain of pneumolysin, though less than that observed with the gene deletion mutant, suggests that complement activation by pneumolysin has a significant role in the pathology observed in this model of corneal infection.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7606914     DOI: 10.3109/02713689509033527

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  9 in total

1.  Pneumolysin-induced complement depletion during experimental pneumococcal bacteremia.

Authors:  R B Alcantara; L C Preheim; M J Gentry-Nielsen
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

2.  Role of Pneumolysin's complement-activating activity during pneumococcal bacteremia in cirrhotic rats.

Authors:  R B Alcantara; L C Preheim; M J Gentry
Journal:  Infect Immun       Date:  1999-06       Impact factor: 3.441

3.  Development of a Streptococcus pneumoniae keratitis model in mice.

Authors:  Quincy C Moore; Clare C McCormick; Erin W Norcross; Chinwendu Onwubiko; Melissa E Sanders; Jonathan Fratkin; Larry S McDaniel; Richard J O'Callaghan; Mary E Marquart
Journal:  Ophthalmic Res       Date:  2009-07-23       Impact factor: 2.892

4.  Protection from Streptococcus pneumoniae keratitis by passive immunization with pneumolysin antiserum.

Authors:  Sherrina N Green; Melissa Sanders; Quincy C Moore; Erin W Norcross; Kathryn S Monds; Armando R Caballero; Larry S McDaniel; Sherrina A Robinson; Chinwendu Onwubiko; Richard J O'Callaghan; Mary E Marquart
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-01       Impact factor: 4.799

5.  Cholesterol as treatment for pneumococcal keratitis: cholesterol-specific inhibition of pneumolysin in the cornea.

Authors:  Mary E Marquart; Kathryn S Monds; Clare C McCormick; Sherrina N Dixon; Melissa E Sanders; Julian M Reed; Larry S McDaniel; Armando R Caballero; Richard J O'Callaghan
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-06       Impact factor: 4.799

6.  A comparison of pneumolysin activity and concentration in vitro and in vivo in a rabbit endophthalmitis model.

Authors:  Melissa E Sanders; Erin W Norcross; Quincy C Moore; Chinwendu Onwubiko; Lauren B King; Jonathan Fratkin; Mary E Marquart
Journal:  Clin Ophthalmol       Date:  2008-12

7.  Mouse, but not human, ApoB-100 lipoprotein cholesterol is a potent innate inhibitor of Streptococcus pneumoniae pneumolysin.

Authors:  Kristin R Wade; Eileen M Hotze; David E Briles; Rodney K Tweten
Journal:  PLoS Pathog       Date:  2014-09-04       Impact factor: 6.823

Review 8.  A Pyrrhic Victory: The PMN Response to Ocular Bacterial Infections.

Authors:  Erin T Livingston; Md Huzzatul Mursalin; Michelle C Callegan
Journal:  Microorganisms       Date:  2019-11-07

9.  Infectious keratitis: secreted bacterial proteins that mediate corneal damage.

Authors:  Mary E Marquart; Richard J O'Callaghan
Journal:  J Ophthalmol       Date:  2013-01-08       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.